TTE_PVV_1_36: Evaluation in 15 Participants of Blood Flow, Comfort and Efficiency, Using 1 vs 36 Hz Stimulation Via Textile Electrodes
Study Details
Study Description
Brief Summary
Muscle contractions induced by calf low-intensity neuromuscular electrical stimulation (C-LI-NMES) can increase venous return and may reduce venous thromboembolism. This study aimed to compare the effect of different C-LI-NMES frequencies and plateau times on hemodynamics, discomfort and energy efficiency, when applied via sock-integrated transverse textile electrodes.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Fifteen healthy participants were stimulated via two 3x3cm transverse textile electrodes integrated in a sock, with ten different combinations of frequency (1Hz or 36Hz) and plateau times (0.5/1.5/3/5/7s), with gradually increasing NMES-intensity until plantar flexion-induction. At this point, popliteal peak venous velocity (PVV), time-averaged mean velocity (TAMV) and ejection volume (EV) were assessed by Doppler-ultrasound, discomfort by a numerical rating scale (NRS, 0-10) and values for current amplitude and energy were calculated based on the NMES-deviceĀ“s intensity level. Values expressed with median (interquartile range), significance set to p<0.05.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Single arm where repeated measures where performed in 15 participants. Each of the 15 participants in the arm was, in addition to the resting state (no intervention), exposed to 10 different interventions repeated after each other to enable repeated measures of the outcomes. |
Device: Chattanooga Physio, DJO, neuromuscular electrical stimulation
Neuromuscular electrical stimulation (NMES) was applied with a device called Chattanooga Physio (DJO), testing 10 different combinations of parameter-settings. The parameter-settings that were varied and combined were frequency (1Hz and 36Hz) and plateau times (0.5s, 1.5s, 3s, 5s, 7s). The NMES was applied to the calf of the participants via transversally placed textile electrodes (3x3 cm) integrated in a sock starting with very low current amplitude followed by gradual small increases in current amplitude until induction of ankle plantar flexion, at which time-point the outcomes where measured.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Peak venous velocity (PVV) [Day 1 at rest (baseline, no intervention) and when ankle plantar flexion was induced by the intervention]
Peak venous velocity (centimeters per second) will be assesed by Doppler ultrasound of in the popliteal vein
- Time averaged mean velocity (TAMV) [Day 1 at rest (baseline, no intervention) and when ankle plantar flexion was induced by the intervention]
Time averaged mean velocity will be assesed by Doppler ultrasound in the popliteal vein (centimeters per second)
- Average duration of blood pulse (ADBP) [Day 1 at rest (baseline, no intervention) and when ankle plantar flexion was induced by the intervention]
Average duration of blood pulse will be assesed by Doppler ultrasound in the popliteal vein (seconds)
- Ejection volume (EV) [Day 1 at rest (baseline, no intervention) and when ankle plantar flexion was induced by the intervention]
Ejection volume of blood will be assesed by Doppler ultrasound in the popliteal vein (milliliters)
Secondary Outcome Measures
- Numerical rating scale (NRS) [Day 1 during ankle plantar flexion was induced by the intervention]
Discomfort estimated using a numerical rating scale from 0 (no pain) to 10 (worst pain)
- Current amplitude [Day 1 during ankle plantar flexion was induced by the intervention]
Current amplitude in milliampere (mA) will be assessed by using stepwise increases (typically 1mA) on the NMES device until a plantar flexion is induced
- Energy [Day 1 during ankle plantar flexion was induced by the intervention]
Energy per stimulation cycle in millijoule (mJ) will be assessed by using stepwise increases (typically 1mA) on the NMES device until a plantar flexion is induced, at which point the energy consumption (mJ) is calculated.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Age 18-99 years of age
-
Voluntary participation
Exclusion Criteria:
-
Pregnancy
-
Pacemaker
-
Ongoing thromboprophylaxis
-
Skin wounds
-
Vascular abnormalities
-
Previous vascular system surgery in the lower limbs
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Karolinska university Hospital | Stockholm | Sweden | 17176 |
Sponsors and Collaborators
- Karolinska University Hospital
Investigators
- Principal Investigator: Paul Ackermann, PhD, MD, Karolinska Institutet
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- TTE_PVV_1_vs_36_Hz